Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma.
about
HER2 as a therapeutic target in head and neck squamous cell carcinomaGenome stability pathways in head and neck cancersEpidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacyEGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cellsDifferences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinomaEpidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomasA new gamboge derivative compound 2 inhibits cancer stem-like cells via suppressing EGFR tyrosine phosphorylation in head and neck squamous cell carcinoma.Tongue carcinoma infrequently harbor common actionable genetic alterationsEpidermal growth factor receptor expression in different subtypes of oral lichenoid diseaseIsolation and genomic characterization of stem cells in head and neck cancer.The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancerPhosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samplesImmunotherapy for head and neck cancer: advances and deficiencies.Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy.Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinoma.Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers.EGFR status in oral squamous cell carcinoma: comparing immunohistochemistry, FISH and CISH detection in a case series studyPhase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neckTreatment of recurrent metastatic head and neck cancer: focus on cetuximab.Biomolecular markers in cancer of the tongue.Targeting EGFR resistance networks in head and neck cancer.Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma.The emerging era of personalized therapy in squamous cell carcinoma of the head and neck.Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications.An analysis of the epidemiological and etiological factors of oral tumors of young adults in a Central-Eastern European population.Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistanceAn open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck.Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology.Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC).Gene status of head and neck squamous cell carcinoma cell lines and cetuximab-mediated biological activities.Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.Targeting ERBB receptors shifts their partners and triggers persistent ERK signaling through a novel ERBB/EFNB1 complex.Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.Influence of allelic Variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer treated with radiotherapy plus cetuximab.Helioxanthin suppresses the cross talk of COX-2/PGE2 and EGFR/ERK pathway to inhibit Arecoline-induced Oral Cancer Cell (T28) proliferation and blocks tumor growth in xenografted nude mice.Epidermal growth factor receptor expression is predictive of poor prognosis in feline cutaneous squamous cell carcinoma.Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx.Overexpression of CXCR4 promotes invasion and migration of non-small cell lung cancer via EGFR and MMP-9.
P2860
Q27026178-8D99CD12-02FB-433A-B8EA-F8FB52FA8C1AQ28391355-54D2C0E2-5E68-4577-9C00-04A5B27C918AQ28475894-5D6E44E1-0E71-48E5-9ADA-229BC82D29CCQ28481290-0CA5794B-86F6-469C-A3FF-A48880207286Q33498941-44240716-5043-4152-A4B8-952321B76EA1Q33575439-30355833-1280-47A0-B432-7ABCDBE08B07Q33982339-4C57B0FB-A3B0-40BE-8928-EA8844B96D2AQ34256064-ACA7F6FC-4180-4FF7-91D0-EA7343EB3D9FQ34317770-A04B2B99-1455-4920-85C0-81C51AF1B681Q34459980-0129DFF0-41B4-4B31-84E4-6DA53E0A57F2Q34622547-28B56DB9-690C-4FC1-95A2-175554F73D68Q34760619-3398C8A3-5F0C-4730-A954-8F6ABB24AEB0Q35072040-8C5D4725-A6D1-49B0-B7B1-53346F11BA9AQ35165488-1C470B88-E035-4FD9-A021-1F1880D6E70BQ35191014-6D00EB13-C2F1-4346-96A5-F1DC2EBB38FBQ35571452-EBD280D5-86F8-4E6D-BCEF-C136F2E6471DQ36584164-65B1EA25-1287-4BEE-8B47-E87449F28766Q36801917-F75FB67A-F8DA-4352-B878-D154758720F1Q37218978-6CF3794C-4AD6-4D33-8D50-B35107693449Q37310520-BE0CA4FA-DFB3-45D9-939E-341001A0EE1AQ37405633-F915CE9A-1D3E-4579-8792-2806CD52EE1FQ37690668-03C3BA37-55E1-44FC-ADE0-A3FE3C4EA881Q37925133-C3CA59FE-62D8-4B80-A773-6DFD1DA9410FQ38087239-344DD5C1-C155-41B2-BABB-EB32044EB919Q38104316-09CCCAEF-DAF4-4DFA-858F-8FB54002A80DQ38118934-920BFC21-C508-49EE-85FF-9E78DEF4B1D8Q38432573-621DACD0-349B-495A-AE41-B978969617CAQ38869420-887566FB-F250-4315-8D67-C5AE6620A588Q39073840-0DAA0407-C5E3-4BF4-BA92-786C0A1D9763Q39154481-221E783F-B86C-43FA-AFC4-917B84B11379Q39532332-72E8AFD4-6774-47BB-92D2-5417967FE0C2Q39545323-39922090-B229-4071-B493-E1A5A32F05A9Q40248639-53D387C7-1BEE-4C4A-8D72-08711C02A494Q40392098-B3EA55B4-3E35-4D85-956A-C92FC54352B4Q40657619-6B6B6F90-4676-4C91-BC6A-2872F2AF5C7AQ41512181-DCE3698C-670C-4F95-AF61-CF049AA20B48Q42700365-118F6F18-1F90-4D29-A90F-869530176AA0Q43741553-7E344772-2CA1-427C-8DF4-AF586D96BBC2Q45203079-F118A22D-CC74-45CB-BE45-52F8EB537619Q47654279-B172DBE9-4323-4D7B-8600-119C77FD028B
P2860
Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Expression and mutation analys ...... neck squamous cell carcinoma.
@en
Expression and mutation analys ...... neck squamous cell carcinoma.
@nl
type
label
Expression and mutation analys ...... neck squamous cell carcinoma.
@en
Expression and mutation analys ...... neck squamous cell carcinoma.
@nl
prefLabel
Expression and mutation analys ...... neck squamous cell carcinoma.
@en
Expression and mutation analys ...... neck squamous cell carcinoma.
@nl
P2093
P1433
P1476
Expression and mutation analys ...... neck squamous cell carcinoma.
@en
P2093
Beyhan Cengiz
Esra Gunduz
Hitoshi Nagatsuka
Kadir Demircan
Kenji Shimizu
Kunihiro Fukushima
Levent Bekir Beder
Mahmoud A L Sheikh Ali
Masae Fujii
Mehmet Gunduz
P2860
P304
P356
10.1111/J.1349-7006.2008.00861.X
P577
2008-08-01T00:00:00Z